No Effect of Immunogenicity on Pharmacokinetics, Efficacy, and Safety of the Oligonucleotide Telomerase Inhibitor Imetelstat in Lower‐Risk Myelodysplastic Syndromes. - Lennox, Ashley L.; Huang, Fei; González‐Sales, Mario; Wan, Ying; Sun, Libo; Berry, Tymara; Feller, Faye; Morcos, Peter N. (CTS: Clinical & Translational Science, 2025)